News
-
-
PRESS RELEASE
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025
Press release on total voting rights and shares of the Company as of April 30, 2025 under Article 223-16 of the General Regulations of the Autorité des Marchés Financiers -
-
-
-
-
-
-
-
PRESS RELEASE
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
DBV Technologies secures financing of up to $306.9 million (€284.5 million) to advance Viaskin Peanut Patch through FDA submission and US commercial launch. Investors include MPM BioImpact, Adage Capital Management, Janus Henderson Investors, and more